Jacques R. Essinger
Chief Executive Officer
Symetis
Switzerland
Biography
Jacques Essinger was appointed CEO of Symetis in 2004, and the company's turnaround to develop and establish Symetis's ACURATE technology platform. He started his career as R&D director of a US-based CT scan image processing company, then co-founded and became CEO of a Swiss orthopedics company, and was subsequently appointed general manager of a US surgical tool company. In 1997 he was appointed CEO of Modex Therapeutics, which he led through a number of VC financing rounds, an IPO on the Swiss Exchange in 2000, a merger with Netherlands-based IsoTis in 2002, and the acquisition of US-based Gensci Orthobiologics in 2003. Dr. Essinger holds an MS degree in Physics, and a PhD in Biomechanics from the Swiss Federal Institute of Technology in Lausanne.
Research Interest
Biomechanics
